文献速递临床试验与 GCP真实世界研究与卫生经济

远程医疗家庭管理在慢性心力衰竭合并2型糖尿病患者中的应用:一项随机对照试验的研究方案

Telemedicine home-based management in patients with chronic heart failure and diabetes type II: study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2024-05-21

本研究为随机对照试验方案,针对慢性心力衰竭合并2型糖尿病患者,1:1随机分为干预组和对照组,干预组接受基于家庭的远程协助、远程会诊、远程监测及每日步数追踪等,对照组接受常规护理。主要结局为6个月时6分钟步行距离较基线的变化,数据按意向性治疗原则分析。

要点

  • 干预组接受护士个案管理师支持的居家远程协助及每日体力活动督促。
  • 主要结局为6分钟步行试验距离从基线至6个月的变化。
  • 数据将按意向性治疗原则进行分析。

核心结论

  • 本研究将提供证据,评估远程医疗家庭管理模式在维持心力衰竭合并2型糖尿病患者正确生活方式、改善自我管理、增强疾病赋权及提高早期识别症状能力方面的效果。

研究设计与样本

  • 研究方案为随机对照试验,在计划的门诊心脏科评估期间招募符合条件的患者,按1:1比例随机分配至干预组或对照组。

主要发现

  • 干预组接受护士个案管理师通过结构化家庭远程协助项目提供的支持,以及教练对日常体力活动的督促,并可获得心脏科医生和糖尿病专科医生的远程会诊、生命体征远程监测和每日步数追踪。
  • 应用程序记录并监测每日药物治疗、血糖、血压、心率及其他临床参数,患者可通过聊天和视频会议系统自我报告症状并与护士个案管理师沟通。
  • 对照组接受常规护理。
  • 数据收集在干预前和基线后6个月时通过新的门诊心脏科评估进行。
  • 主要结局是测量6分钟步行试验中从基线至6个月后步行距离的差异,关键次要结局包括改善疾病状态和体力活动概况。

关键数值与推荐

  • 主要结局为6分钟步行试验距离从基线至6个月的变化。
  • 关键次要结局包括疾病状态和体力活动概况的改善。
  • 数据将按意向性治疗原则进行分析。
  • 试验注册号:ClinicalTrials.gov NCT05633784,注册日期为2022年11月30日。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Heart failure and type 2 diabetes are prevalent public health issues in Europe. These complex chronic conditions require extensive pharmacological management, ongoing self-care, and behavioral changes. Despite the known benefits of lifestyle changes, such as regular exercise and better control of blood sugar levels, patients may need help implementing the recommended changes. This study aims to assess the effectiveness of a telemedicine program for managing heart failure and type 2 diabetes at home. The program focuses on promoting lifestyle changes. METHODS AND ANALYSIS: During scheduled outpatient cardiology evaluations, eligible patients are recruited and randomly assigned to either an intervention or control group in a 1:1 ratio. The intervention group receives support from a nursing case manager through a structured home-based teleassistance program and a trainer for daily physical activity stimulation. They also have access to teleconsultations with cardiologists and diabetes specialists as needed, telemonitoring of vital signs, and daily step tracking. An app records and monitors daily drug treatment, glycemia, blood pressure, heart rate, and other clinical parameters. Patients can also self-report symptoms and communicate via a chat and videoconference system with a Nurse Case Manager. The control group receives routine care. Data collection occurs before intervention and 6 months after baseline during a new outpatient cardiology evaluation. The primary outcome is to measure the difference in the distance walked during a 6-min walk test between baseline and after 6 months. The key secondary outcomes include improving the disease status and physical activity profile. Data will be analyzed according to the intention-to-treat principles. DISCUSSION: This study will provide evidence on the efficacy of a telemedicine home-based management model to maintain correct lifestyles in patients with both heart failure and type 2 diabetes, improving self-management, their empowerment on the diseases, and increasing their knowledge and ability to recognize symptoms early. TRIAL REGISTRATION: ClinicalTrials.gov NCT05633784. Registered on November 30, 2022.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Bernocchi P, Giudici V, Borghi G, et al. Telemedicine home-based management in patients with chronic heart failure and diabetes type II: study protocol for a randomized controlled trial. Trials. 2024. PMID: 38773662. doi:10.1186/s13063-024-08171-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。